Explore advanced treatment for graft versus host disease at Liv Hospital. From standard therapies to cutting-edge Mesenchymal Stem Cells (MSCs) and ECP.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Treatment and Procedures

Therapies and Innovations

The diagnosis of Graft Versus Host Disease (GVHD) can be unsettling, but the landscape of treatment has expanded significantly in recent years. At Liv Hospital, our philosophy is not just to suppress the symptoms, but to recalibrate the immune system.

The primary goal of treatment for graft versus host disease is a delicate balancing act: we must suppress the “new” immune cells enough to stop them from attacking your organs, but not so much that we lose the “Graft-Versus-Tumor” effect—the beneficial process where donor cells destroy remaining cancer cells. Our multidisciplinary team tailors this balance for every patient, moving from standard protocols to advanced cellular therapies when necessary.

What is the First Line of Defense?

For most patients diagnosed with acute or chronic GVHD, the immediate goal is to reduce inflammation.

Icon LIV Hospital

Systemic Corticosteroids

STEM CELL

Corticosteroids (such as prednisone or methylprednisolone) remain the “gold standard” and first step in treatment. They work rapidly to suppress the immune response.

  • Topical application: For mild skin rashes, steroid creams may be sufficient.
  • Systemic application: For internal organ involvement (liver/gut), intravenous or oral steroids are prescribed.
  • The Tapering Process: Once symptoms improve, doctors slowly reduce the dosage over weeks or months to prevent the disease from flaring back up.
Icon 1 LIV Hospital

Immunosuppressive Maintenance

Indications Related to Disease Progression

To allow the patient to eventually lower their steroid dose (and avoid long-term steroid side effects), physicians often add calcineurin inhibitors like cyclosporine or tacrolimus.

These drugs work by inhibiting T-cell activation, essentially “calming down” the donor cells.

What if Standard Treatments Don't Work?

Approximately 30-50% of patients may not respond fully to steroids, a condition known as Steroid-Refractory GVHD. In the past, this was difficult to treat, but today, Liv Hospital offers robust “second-line” and “third-line” therapies.

Targeted Therapies (Kinase Inhibitors)

Newer medications target specific pathways inside the immune cells.

  • Ruxolitinib (Jakafi): The first FDA-approved drug specifically for acute GVHD that resists steroids. It blocks the JAK1/JAK2 pathways involved in inflammation.
  • Ibrutinib (Imbruvica): Often used for chronic GVHD, particularly when it affects the skin and mouth.
STEM CELL

How Does Extracorporeal Photopheresis (ECP) Help?

For patients who need an alternative to heavy medication, Liv Hospital utilizes Extracorporeal Photopheresis (ECP). Think of this as “dialysis for your white blood cells.”

The Procedure:

  1. Blood is drawn from the patient.
  2. White blood cells are separated and treated with a photo-active drug.
  3. The cells are exposed to ultraviolet (UV) light inside the machine.
  4. The treated cells are returned to the body.

The Benefit: This process triggers the treated cells to die (apoptosis) in a controlled way. When the body cleans up these dying cells, it signals the immune system to “reset” and stop the attack, all without suppressing the entire immune system like chemotherapy would.

Advanced Cellular Therapy: The Liv Advantage

This is where Liv Hospital distinguishes itself as a center of excellence for international patients. Through our LivMedCell (Regenerative Medicine Stem Cell Manufacturing Center), we produce and utilize advanced cellular products that are not widely available in standard clinical settings.

Mesenchymal Stem Cells (MSCs)

When GVHD is severe or refractory to other treatments, we may utilize Mesenchymal Stem Cells.

  • What they are: MSCs are cells found in bone marrow and tissue that act as “paramedics” for the immune system.
  • How they work: Unlike the donor T-cells that attack, MSCs are immunomodulatory. They release chemical signals that suppress inflammation and promote tissue repair.
  • The Liv Protocol: Our GMP-certified laboratory manufactures high-quality MSCs derived from umbilical cord or bone marrow sources, ensuring potency and safety for therapeutic use.

Supportive Care and Rehabilitation

Treating GVHD is not just about medications; it is about preserving the body’s function.

  • Intravenous Immunoglobulin (IVIG): Infusions to boost the immune system against infections.
  • Physical Therapy: To prevent joint stiffness (contractures) in chronic GVHD.
  • Nutritional Support: Specialized diet plans for patients with gut GVHD to ensure nutrient absorption without irritation.

30
Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical expertise and hospitality to every individual who walks through our doors.  

Book a Free Certified Online Doctor Consultation

Doctors

Table of Contents

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

How long does treatment last?

There is no fixed timeline. Acute GVHD treatment might last a few months. Chronic GVHD treatment is often a longer journey, potentially lasting 1 to 3 years. The goal is always to eventually wean off all immunosuppression (tolerance induction).

Long-term steroid use can cause bone weakening, high blood sugar, muscle weakness, and increased risk of infection. This is why our team aggressively seeks to transition patients to “steroid-sparing” treatments like ECP or MSCs as soon as possible.

Yes, MSCs have an excellent safety profile. Because they do not express the HLA markers that trigger rejection, they are generally well-tolerated and do not cause GVHD themselves.

Never stop GVHD medication abruptly. Doing so can cause a severe “flare” where symptoms return more aggressively. Dose reduction must be done under strict doctor supervision.

As an academic medical center, Liv Hospital often participates in international clinical trials, giving patients access to novel therapies before they are widely available. Ask your International Patient Coordinator about current eligibility.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Contact Us to Get Information!

Contact
Your Comparison List (you must select at least 2 packages)